JP2025506504A5 - - Google Patents

Info

Publication number
JP2025506504A5
JP2025506504A5 JP2024547671A JP2024547671A JP2025506504A5 JP 2025506504 A5 JP2025506504 A5 JP 2025506504A5 JP 2024547671 A JP2024547671 A JP 2024547671A JP 2024547671 A JP2024547671 A JP 2024547671A JP 2025506504 A5 JP2025506504 A5 JP 2025506504A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkyl
deuterium
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547671A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506504A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/053744 external-priority patent/WO2023156450A1/en
Publication of JP2025506504A publication Critical patent/JP2025506504A/ja
Publication of JP2025506504A5 publication Critical patent/JP2025506504A5/ja
Pending legal-status Critical Current

Links

JP2024547671A 2022-02-15 2023-02-15 治療用フェネチルアミン組成物及び使用方法 Pending JP2025506504A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263268019P 2022-02-15 2022-02-15
US202263268022P 2022-02-15 2022-02-15
US63/268,019 2022-02-15
US63/268,022 2022-02-15
US202263386375P 2022-12-07 2022-12-07
US63/386,375 2022-12-07
PCT/EP2023/053744 WO2023156450A1 (en) 2022-02-15 2023-02-15 Therapeutic phenethylamine compositions and methods of use

Publications (2)

Publication Number Publication Date
JP2025506504A JP2025506504A (ja) 2025-03-11
JP2025506504A5 true JP2025506504A5 (https=) 2026-02-20

Family

ID=85278498

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547671A Pending JP2025506504A (ja) 2022-02-15 2023-02-15 治療用フェネチルアミン組成物及び使用方法

Country Status (7)

Country Link
US (1) US20250236589A1 (https=)
EP (1) EP4479373A1 (https=)
JP (1) JP2025506504A (https=)
KR (1) KR20240153566A (https=)
AU (1) AU2023222397A1 (https=)
CA (1) CA3244275A1 (https=)
WO (1) WO2023156450A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021328671A1 (en) 2020-08-18 2023-02-16 Cybin Irl Limited Phenethylamine derivatives, compositions, and methods of use
WO2025228547A1 (en) * 2024-05-01 2025-11-06 Cybin Irl Limited Processes for preparing phenethylamine compounds
WO2026030444A1 (en) * 2024-07-30 2026-02-05 Otsuka America Pharmaceutical, Inc Compounds useful for the treatment of disorders and methods related thereto

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US5612059A (en) 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5798119A (en) 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
ID28302A (id) 1999-01-14 2001-05-10 Teijin Ltd Alat untuk mengumpankan suatu bubuk dalam jumlah tertentu
GB0121568D0 (en) 2001-09-06 2001-10-24 Optinose As Nasal delivery device
CN1736502A (zh) 1999-03-03 2006-02-22 奥普蒂诺斯公司 鼻传送装置
GB0114272D0 (en) 2001-06-12 2001-08-01 Optinose As Nasal delivery device
GB0019715D0 (en) 2000-08-10 2000-09-27 Pa Consulting Services Device for delivering physiologically active agent in powdered form
ZA200306564B (en) 2001-02-26 2004-10-15 Optinose As Nasal devices.
WO2003026559A2 (en) 2001-09-28 2003-04-03 Kurve Technology, Inc Nasal nebulizer
GB0207422D0 (en) 2002-03-28 2002-05-08 Optinose As Nasal devices
GB0207817D0 (en) 2002-04-04 2002-05-15 Optinose As Nasal devices
GB0209494D0 (en) 2002-04-25 2002-06-05 Optinose As Nasal devices
US7267121B2 (en) 2004-04-20 2007-09-11 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
RU199823U1 (ru) 2020-06-10 2020-09-21 Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий Устройство для лечения бронхолегочных заболеваний

Similar Documents

Publication Publication Date Title
JP2025506504A5 (https=)
JP2023540017A5 (https=)
JP2023539113A5 (https=)
JP2025505745A5 (https=)
JP2023526856A5 (https=)
JP2021523200A5 (https=)
JP2024529839A5 (https=)
JP2024520481A5 (https=)
JP2025509697A5 (https=)
JP2013010792A5 (https=)
JP2009531277A5 (https=)
JP2005508349A5 (https=)
JP2021528427A5 (https=)
RU2011119990A (ru) Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
JP2024522065A5 (https=)
JP2023531709A5 (https=)
JP2004511556A5 (https=)
JP2012523440A5 (https=)
AR066904A1 (es) Pirrolopiridinas y pirazolopiridinas sustituidas como moduladores de las quinasas, una composicion farmaceutica que las incluye y su uso en el tratamiento del cancer
JP2012521994A5 (https=)
JP2020063289A5 (https=)
RU2010113358A (ru) Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов
JP2025111616A5 (https=)
JP2023518044A5 (https=)
JP2019530674A5 (https=)